К основному контенту

Ditropan

Ditropan

     * Generic Name: oxybutynin tablets
     * Brand Name: Ditropan


     * What is oxybutynin (Ditropan, Ditropan XL, Urotrol)?
     * What are the possible side effects of oxybutynin (Ditropan,
       Ditropan XL, Urotrol)?
     * What is the most important information I should know about
       oxybutynin (Ditropan, Ditropan XL, Urotrol)?
     * What should I discuss with my healthcare provider before using
       oxybutynin (Ditropan, Ditropan XL, Urotrol)?
     * How should I take oxybutynin (Ditropan, Ditropan XL, Urotrol)?
     * What happens if I miss a dose (Ditropan, Ditropan XL, Urotrol)?
     * What happens if I overdose (Ditropan, Ditropan XL, Urotrol)?
     * What should I avoid while using oxybutynin (Ditropan, Ditropan
       XL, Urotrol)?
     * What other drugs will affect oxybutynin (Ditropan, Ditropan XL,
       Urotrol)?
     * Where can I get more information (Ditropan, Ditropan XL,
       Urotrol)?

What is oxybutynin (Ditropan, Ditropan XL, Urotrol)?

   Oxybutynin reduces muscle spasms of the bladder and
   urinary tract.

   Oxybutynin is used to treat symptoms of overactive bladder, such as
   frequent or urgent urination, incontinence (urine leakage), and
   increased night-time urination.

   Oxybutynin may also be used for purposes not listed in this medication
   guide.

What are the possible side effects of oxybutynin (Ditropan, Ditropan XL,
Urotrol)?

   Get emergency medical help if you have any of these signs of an
   allergic reaction: hives; difficult breathing; swelling of your face,
   lips, tongue, or throat.

   Stop using oxybutynin and call your doctor at once if you have:
     * feeling very thirsty or hot, being unable to urinate, heavy
       sweating, or hot and dry skin;
     * severe stomach pain or constipation;
     * blurred vision, tunnel vision, eye pain, or seeing halos
       around lights;
     * pain or burning when you urinate; or
     * little or no urinating.

   Common side effects may include:
     * dry mouth;
     * dry eyes, blurred vision;
     * mild constipation; or
     * dizziness, drowsiness.

   This is not a complete list of side effects and others may occur. Call
   your doctor for medical advice about side effects. You may report side
   effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about oxybutynin
(Ditropan, Ditropan XL, Urotrol)?

   You should not use oxybutynin if you have untreated or uncontrolled
   narrow-angle glaucoma, a blockage in your digestive tract (stomach
   or intestines), or if you are unable to urinate.

   Ditropan Patient Information including How Should I Take
   Urinary Incontinence in Women: Loss of Bladder Control?

   Urinary Incontinence in Women Slideshow Pictures
   Urinary Incontinence in Men:Products, Diet, & Lifestyle

   Urinary Incontinence in Men Slideshow Pictures
   Urinary Incontinence:Foods and Drinks That Make You Gotta Go

   Food & Drinks That Make You Gotta Go Slideshow Pictures

What should I discuss with my healthcare provider before using oxybutynin
(Ditropan, Ditropan XL, Urotrol)?

   You should not use oxybutynin if you are allergic to it, or if you
   have:
     * untreated or uncontrolled narrow-angle glaucoma;
     * a blockage in your digestive tract (stomach or intestines); or
     * if you are unable to urinate.

   To make sure oxybutynin is safe for you, tell your doctor if you have:
     * glaucoma;
     * liver disease;
     * kidney disease;
     * an enlarged prostate;
     * ulcerative colitis;
     * Parkinson's disease;
     * a nerve disorder that affects your heart rate, blood pressure, or
       digestion;
     * a muscle disorder such as myasthenia gravis; or
     * a stomach disorder such as gastroesophageal reflux disease
       (GERD) or slow digestion.

   This medicine is not expected to harm an unborn baby. Tell your doctor
   if you are pregnant or plan to become pregnant.

   It is not known whether oxybutynin passes into breast milk or if it
   could harm a nursing baby. Tell your doctor if you are breast-feeding a
   baby.

How should I take oxybutynin (Ditropan, Ditropan XL, Urotrol)?

   Follow all directions on your prescription label. Do not take this
   medicine in larger or smaller amounts or for longer than recommended.

   Take oxybutynin with a full glass of water. Try to take the medicine at
   the same time each day.

   Oxybutynin may be taken with or without food.

   Do not crush, chew, or break an extended-release tablet. Swallow it
   whole.

   Measure liquid medicine with the dosing syringe provided, or with a
   special dose-measuring spoon or medicine cup. If you do not have a
   dose-measuring device, ask your pharmacist for one.

   Store at room temperature away from moisture and heat.

   Ditropan Patient Information including If I Miss a Dose
   Urinary Incontinence in Women: Loss of Bladder Control?

   Urinary Incontinence in Women Slideshow Pictures
   Urinary Incontinence in Men:Products, Diet, & Lifestyle

   Urinary Incontinence in Men Slideshow Pictures
   Urinary Incontinence:Foods and Drinks That Make You Gotta Go

   Food & Drinks That Make You Gotta Go Slideshow Pictures

What happens if I miss a dose (Ditropan, Ditropan XL, Urotrol)?

   Take the missed dose as soon as you remember. Skip the missed dose if
   it is almost time for your next scheduled dose. Do not take extra
   medicine to make up the missed dose.

What happens if I overdose (Ditropan, Ditropan XL, Urotrol)?

   Seek emergency medical attention or call the Poison Help line at
   1-800-222-1222.

What should I avoid while using oxybutynin (Ditropan, Ditropan XL, Urotrol)?

   This medication may cause blurred vision and may impair your thinking
   or reactions. Be careful if you drive or do anything that requires you
   to be alert and able to see clearly.

   Avoid becoming overheated or dehydrated during exercise and in hot
   weather. Oxybutynin can decrease perspiration and you may be more
   prone to heat stroke.

What other drugs will affect oxybutynin (Ditropan, Ditropan XL, Urotrol)?

   Taking this medicine with other drugs that make you sleepy can worsen
   this effect. Ask your doctor before taking oxybutynin with a sleeping
   pill, narcotic pain medicine, muscle relaxer, or medicine for
   anxiety, depression, or seizures.

   Tell your doctor about all your current medicines and any you start or
   stop using, especially:
     * other bladder or urinary medicines such as darifenacin,
       fesoterodine, tolterodine, solifenacin;
     * bronchodilators such as ipratropium or tiotropium;
     * cold or allergy medicine that contains an antihistamine;
     * medication for Parkinson's disease; or
     * medication to treat excess stomach acid, stomach ulcer,
       motion sickness, or irritable bowel syndrome.

   This list is not complete. Other drugs may interact with oxybutynin,
   including prescription and over-the-counter medicines, vitamins, and
   herbal products. Not all possible interactions are listed in this
   medication guide.

Where can I get more information (Ditropan, Ditropan XL, Urotrol)?

   Your pharmacist can provide more information about oxybutynin.
     __________________________________________________________________


Комментарии

Отправить комментарий

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...
4 комментария
Далее...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...
4 комментария
Далее...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...
Отправить комментарий
Далее...